[Movalis treatment of low back pain (LBP)].
OBJECTIVE
To assess the response to nonsteroid antiinflammatory drug movalis in LBP syndrome.


METHODS
Movalis was given in daily dose 15 mg for 7 days, then 7.5 mg daily for 14 days to 22 patients with LBS aged 34-56 years. All the patients had lumbosacral intervertebral osteochondrosis complicated with secondary radiculitis or myofascial syndrome.


RESULTS
Movalis noticeably relieved pain syndrome. At the end of the treatment two-thirds of the patients were able to move. Tolerance of the drug was good, satisfactory and bad in 10, 7 and 1 patients, respectively.


CONCLUSIONS
Movalis is effective in LBP syndrome.
Shostak
N A
NA
Aksenova
A V
AV
Shemetov
D A
DA
Arinina
E E
EE
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D017116:Low Back Pain / Q000188:drug therapy* / Q000209:etiology / Q000534:rehabilitation; D008297:Male; D000077239:Meloxicam; D008875:Middle Aged; D010007:Osteochondritis / Q000150:complications / Q000188:drug therapy; D010147:Pain Measurement; D011843:Radiculopathy / Q000150:complications / Q000188:drug therapy; D013122:Spinal Diseases / Q000150:complications / Q000188:drug therapy; D013843:Thiazines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam